Soluble Biomarker Signature to Predict Outcome of Patients with Non-Small-cell Lung Cancer (NSCLC) Treated with Anti-Pd1/pdl1 Monoclonal Antibodies.
Journal of Clinical Oncology(2019)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of Clinical Oncology(2019)